Human mesencephalon cell lines and methods of use therefor

Details Human mesencephalon cell lines and methods of use therefor Human mesencephalon cell lines and methods of use therefor

2005-07-05

2005-07-05

Fredman, Jeffrey (Department: 1636)

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

Primate cell, per se

C435S069100, C435S320100, C435S325000, C435S455000, C435S363000, C435S366000, C435S375000, C435S377000, C435S383000, C435S384000

Reexamination Certificate

active

06913925

ABSTRACT:
Conditionally-immortalized human mesencephalon cell lines are provided. Such cell lines, which may be clonal, may be used to generate neurons, including dopaminergic neurons. The cell lines and/or differentiated cells may be used for the development of therapeutic agents to prevent and treat a variety of neurological diseases such as Parkinson's disease. The cell lines and/or differentiated cells may also be used in assays and for the general study of mesencephalon cell development and differentiation.

REFERENCES:
patent: 5411883 (1995-05-01), Boss et al.
patent: 5750376 (1998-05-01), Weiss et al.
patent: 6197585 (2001-03-01), Stringer
patent: 2 294 946 (1996-05-01), None
patent: WO 91/09936 (1991-07-01), None
patent: WO 96/14398 (1996-05-01), None
patent: WO 96/14400 (1996-05-01), None
Casper et al., EGF enhances the survival of dopamine neurons in rat embryonic mesencephalon primary cell culture, 1991, J Neurosci Res, vol. 30, pp. 372-381.
Nikkhah et al., Platelet-derived growth factor promotes survival of rat and human mesencephalic dopaminergic neurons in culture, 1993, Experimental Brain Research, vol. 92, pp. 516-523.
Hosimaru et al. PNAS. 93:1518-1523, 1996.
Prasad et al. In Vitro. Cell Dev. 30A:596-603, 1994.
Gallyas et al. Neurochem. Res. 22(5):569-575, 1997.
U.S. Appl. No. 08/711,628, to Sah et al., filed Sep. 3, 1996, entitled: “Human CNS Cell Lines and Methods of Use Therefor” allowed Feb. 25, 2003.
di Porzio et al., “Establishment and Characterization of a Neuronal Cell Line, Obtained by c-myc Immortalization of Mouse Mesencephalic Cells,”Society for Neuroscience Abstracts 18(1-2), p. P410, 1992.
Hartikka et al., “Cyclic AMP, but not Basic FGF, Increases the In Vitro Survival of Mesencephalic Dopaminergic Neurons and Protects Them from MPP-Induced Degeneration,”Journal of Neuroscience Research 32:190-201, 1992.
Heller et al., “Glial-Derived Neurotrophic Factor (GDNF) Induced Morphological Differentiation of an Immortalized Monoclonal Hybrid Dopaminergic Cell Line of Mesencephalic Neruonal Origin,”Brain Research 725:132-136, 1996.
Sah et al., “Bipotent Progenitor Cell Lines from the Human CNS,”Nature Biotechnology 15(6): 574-580, 1997.
Zhou et al., “The Response of Human and Rat Fetal Ventral mesencephalon in Culture to the Brain-Derived Neurotrophic Factor Treatment,”Brain Research 656:147-156, 1994.

Affiliated with

Also associated with

Rating

Human mesencephalon cell lines and methods of use therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human mesencephalon cell lines and methods of use therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human mesencephalon cell lines and methods of use therefor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3387900